F
Fortrea Holdings Inc. (FTRE)
NMS – Real vaqt narxi. Valyuta: USD
9.07
-0.48 (-5.03%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
9.07
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 4:34 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NMS – Real vaqt narxi. Valyuta: USD
9.07
-0.48 (-5.03%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
9.07
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 4:34 PM EDT
Fortrea Holdings Inc., shartnoma asosida tadqiqotlar olib boruvchi tashkilot bo'lib, farmatsevtika, biotexnologiya va tibbiy asboblar ishlab chiqaruvchi mijozlarga dunyo bo'ylab biofarmatsevtika mahsulotlari va tibbiy asboblarini ishlab chiqish bo'yicha yechimlarni taqdim etadi. U klinik farmakologiyani, jumladan, klinik tadqiqot bo'linmalari, tashqi hamkorliklar, loyiha boshqaruvi, tadqiqotlarni loyihalash va monitoringi, bioanalitika va biomarkyerlar, farmakokinetika, modellashtirish va simulyatsiya, hamda biometsiyani taklif etadi; hamda klinik rivojlantirishni, jumladan, I dan IV gacha bo'lgan klinik tadqiqotlar va haqiqiy dunyo dalillari bo'yicha tadqiqotlar, regulyator masalalar, protokolni loyihalash, operativ rejalashtirish, tadqiqot va markazlarni ishga tushirish, bemorlarni jalb qilish, loyiha boshqaruvi, markaz va tibbiy monitoringni to'liq nazorat qilish, ma'lumotlar boshqaruvi va biostatistika, farmakoko'z qorovulligi, tibbiy yozishmalar va mobil klinik xizmatlarni o'z ichiga oladi. Kompaniya, shuningdek, mahsulotni ishlab chiqish va regulyator masalalar, bozorga kirish va sog'liqni saqlash iqtisodiyoti, hamda natijalarni tadqiq qilish bo'yicha konsalting xizmatlarini, shuningdek, haqiqiy dunyo dalillari bo'yicha xizmatlarni taqdim etadi. Fortrea Holdings Inc. 2023-yilda ro'yxatga olingan va Shimoliy Karolina shtatining Durham shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Alejandro Martinez Galindo | Chief Information Officer |
| Mr. Anshul Thakral | CEO & Director |
| Mr. Dave Cooper | Chief Administrative Officer |
| Mr. Drayton Virkler | President & Chief Commercial Officer |
| Mr. Mark A. Morais | COO & President of Clinical Services |
| Mr. Robert Parks | Chief Accounting Officer |
| Ms. Agnieszka M. Gallagher J.D. | General Counsel |
| Ms. Hima B. Inguva | Head of Corporate Development |
| Ms. Jill McConnell | Chief Financial Officer |
| Ms. Tracy H. Krumme | Senior VP of Investor Relations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2025-11-20 | 8-K | ftre-20251118.htm |
| 2025-11-05 | 8-K | ftre-20251105.htm |
| 2025-09-22 | 8-K | ftre-20250919.htm |
| 2025-08-29 | S-8 | forms-8inducementplan.htm |
| 2025-08-27 | 8-K | ftre-20250821.htm |
| 2025-08-06 | 10-Q | ftre-20250630.htm |
| 2025-06-12 | 8-K | ftre-20250610.htm |
| 2025-06-11 | 8-K | d55989d8k.htm |
| 2025-05-15 | 8-K/A | d917910d8ka.htm |
| 2025-05-12 | 8-K | ftre-20250509.htm |